Surgery: Parathyroidectomy for Severe SHPT
At a Glance
Parathyroidectomy may be considered when kidney-related secondary hyperparathyroidism stays severe despite medication or causes serious mineral problems or symptoms. Surgery can lower the excess hormone, but close monitoring for low calcium and ongoing blood tests are important.
For many people with secondary hyperparathyroidism (SHPT), diet and medications are enough to keep the condition managed. However, in some cases, the parathyroid glands grow so large that they become “autonomous”—meaning they stop responding properly to the body’s signals and to medications [1]. When this happens, a parathyroidectomy (surgical removal of the glands) may be considered [2][3].
When is Surgery Considered?
Surgery is generally considered when SHPT becomes severe, persistent, and “medically refractory” (meaning medications are no longer working or cannot be tolerated) [4]. There is no single PTH cutoff that mandates surgery for everyone; it is an individualized decision. Your doctor may recommend a surgical evaluation if:
- Medical Failure: Your intact PTH (iPTH) remains persistently and severely elevated despite optimization of calcimimetics, vitamin D, and phosphate binders [2][3].
- Mineral Imbalance: You have severe hypercalcemia or hyperphosphatemia that prevents you from taking necessary medications safely [3][5].
- Severe Symptoms: You are suffering from debilitating bone pain, severe persistent itching (pruritus), or unexplained fragility fractures related to high-turnover bone disease [2][6].
Note on Calciphylaxis: Calciphylaxis (painful, dark, or ulcerating skin lesions) is a medical emergency requiring urgent multidisciplinary wound, vascular, and medical care. While parathyroidectomy is sometimes performed for patients with calciphylaxis and severe SHPT, it is not an automatic emergency treatment. Do not delay seeking urgent medical care for painful skin sores while waiting for a surgical consultation [3][7].
Understanding Your Surgical Options
Surgeons typically use one of two main approaches. The choice is individualized based on your anatomy, dialysis status, and whether you plan to have a kidney transplant.
- Subtotal Parathyroidectomy: The surgeon removes 3.5 of the 4 glands, leaving a small piece of the fourth gland in its original place in your neck [8]. This may reduce the risk of permanent low parathyroid function, a consideration for some transplant candidates [9].
- Total Parathyroidectomy with Autotransplantation: All four glands are removed from the neck. A small piece of parathyroid tissue is then “replanted” or autotransplanted into a muscle, like your forearm [8]. If the disease returns, it is easier to address the tissue in the arm than to perform another neck surgery [10].
Surgical Risks and Recovery
Like any operation, a parathyroidectomy carries risks. You should discuss these thoroughly during the informed consent process:
- General Risks: Bleeding, neck hematoma (blood pooling), infection, and risks related to anesthesia.
- Voice Changes: There is a small risk of injury to the recurrent laryngeal nerve, which controls your vocal cords, potentially causing hoarseness.
- Hypoparathyroidism: The surgery could leave you with permanently low parathyroid function, requiring lifelong calcium and vitamin D supplementation.
The Challenge of Hungry Bone Syndrome
A major postoperative challenge is hungry bone syndrome [11]. Because high PTH levels have been pulling calcium from your bones for years, suddenly removing that PTH stimulus causes your bones to act like a dry sponge, rapidly soaking up calcium from your blood [12][13].
This can lead to severe hypocalcemia (low blood calcium). Symptoms include tingling (“pins and needles”) in your fingers, toes, or around your mouth, muscle cramps, spasms (tetany), and in severe cases, seizures or confusion [14]. This requires close hospital monitoring. Your surgical team will check your calcium, phosphate, magnesium, and PTH frequently, and replace calcium and active vitamin D (via IV or orally) according to their protocol [15][16]. Any symptoms of muscle spasms, tingling, or breathing difficulty after surgery should be reported immediately.
Long-Term Outlook
Surgery is generally highly effective at lowering PTH. Many patients see their bone turnover stabilize within a year [17]. However, because the underlying kidney disease remains (if you are on dialysis), there is a possibility that the remaining parathyroid tissue could grow back over the years [18]. Regular blood tests for calcium and PTH will remain a permanent part of your healthcare routine [19].
Common questions in this guide
When is parathyroid surgery considered for severe SHPT?
What is the difference between subtotal and total parathyroidectomy for SHPT?
What is hungry bone syndrome after parathyroidectomy?
What complications can happen after parathyroidectomy?
What follow-up is needed after surgery for renal SHPT?
Should I wait for a surgical visit if I have painful skin sores?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on my lab trends, has my SHPT reached the point where it is considered 'medically refractory' or non-responsive to medications?
- 2.Which surgical approach do you recommend for me—subtotal parathyroidectomy or total parathyroidectomy with autotransplantation—and why?
- 3.Given my preoperative PTH and alkaline phosphatase levels, how high is my risk for developing 'hungry bone syndrome'?
- 4.What is the specific plan for monitoring my calcium and replacing it (IV or oral) immediately after the surgery?
- 5.What are the main surgical risks I should be aware of, including voice changes or bleeding?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (19)
- 1
Current Understanding of Mineral and Bone Disorders of Chronic Kidney Disease and the Scientific Grounds on the Use of Exogenous Parathyroid Hormone in Its Management.
Pazianas M, Miller PD
Journal of bone metabolism 2020; (27(1)):1-13 doi:10.11005/jbm.2020.27.1.1.
PMID: 32190604 - 2
Surgical Management of Secondary Hyperparathyroidism.
Steinl GK, Kuo JH
Kidney international reports 2021; (6(2)):254-264 doi:10.1016/j.ekir.2020.11.023.
PMID: 33615051 - 3
Parathyroidectomy in the Management of Secondary Hyperparathyroidism.
Lau WL, Obi Y, Kalantar-Zadeh K
Clinical journal of the American Society of Nephrology : CJASN 2018; (13(6)):952-961 doi:10.2215/CJN.10390917.
PMID: 29523679 - 4
The Effects of Parathyroidectomy vs Medical Treatments for Secondary Hyperparathyroidism in Patients Undergoing Dialysis: A Meta-Analysis.
Song Z, Wu C, Wang R, et al.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2024; (30(6)):569-576 doi:10.1016/j.eprac.2024.04.002.
PMID: 38583772 - 5
Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder: Synopsis of the Kidney Disease: Improving Global Outcomes 2017 Clinical Practice Guideline Update.
Ketteler M, Block GA, Evenepoel P, et al.
Annals of internal medicine 2018; (168(6)):422-430 doi:10.7326/M17-2640.
PMID: 29459980 - 6
Parathyroid hormone targets in chronic kidney disease and managing severe hyperparathyroidism.
Hawley CM, Holt SG
Nephrology (Carlton, Vic.) 2017; (22 Suppl 2()):47-50 doi:10.1111/nep.13029.
PMID: 28429550 - 7
Parathyroidectomy as a Cure for Calciphylaxis in a Non-Dialysis Chronic Kidney Disease Patient?
Nasr R, Ghazanfar H
The American journal of case reports 2019; (20()):1170-1174 doi:10.12659/AJCR.917105.
PMID: 31395848 - 8
Parathyroidectomy for patients with secondary hyperparathyroidism in a changing landscape for the management of end-stage renal disease.
van der Plas W, Kruijff S, Sidhu SB, et al.
Surgery 2021; (169(2)):275-281 doi:10.1016/j.surg.2020.08.014.
PMID: 33059930 - 9
Comparing subtotal parathyroidectomy and total parathyroidectomy with autotransplantation in renal transplant recipients.
Black KA, Galata G, Schulte KM, Hubbard JG
Gland surgery 2023; (12(8)):1060-1066 doi:10.21037/gs-23-54.
PMID: 37701301 - 10
Predictive value of characteristics of resected parathyroid glands for persistent secondary hyperparathyroidism during parathyroidectomy.
Huang Y, Wang J, Zeng M, et al.
BMC surgery 2023; (23(1)):36 doi:10.1186/s12893-023-01936-5.
PMID: 36788539 - 11
Improved Clinical Outcomes Associated With Hungry Bone Syndrome Following Parathyroidectomy in Dialysis Patients.
Silarat P, Saeseow S, Pathumarak A, et al.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2024; (30(11)):1079-1088 doi:10.1016/j.eprac.2024.08.004.
PMID: 39214462 - 12
Bone metabolism markers and hungry bone syndrome after parathyroidectomy in dialysis patients with secondary hyperparathyroidism.
Ge Y, Yang G, Wang N, et al.
International urology and nephrology 2019; (51(8)):1443-1449 doi:10.1007/s11255-019-02217-y.
PMID: 31264087 - 13
Fatal Hypocalcaemia Due to Hungry Bone Syndrome with Secondary Refractory HyperParathyroidism After Parathyroidectomy: A Case Report.
Radu CP, Daniealopol V, Santini A, et al.
Journal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures) 2019; (5(4)):140-144 doi:10.2478/jccm-2019-0021.
PMID: 31915720 - 14
Hungry Bone Syndrome After Parathyroidectomy for Secondary Hyperparathyroidism: Pathogenesis and Contemporary Clinical Considerations.
Coman A, Tarta C, Marian M, et al.
Journal of clinical medicine 2025; (14(19)) doi:10.3390/jcm14197104.
PMID: 41096184 - 15
Interventions to Reduce the Risk of Hypocalcemia After Parathyroidectomy for People With Advanced Chronic Kidney Disease: A Systematic Review.
Landsberg A, Brockman NK, Sevinc E, et al.
Canadian journal of kidney health and disease 2025; (12()):20543581251358144 doi:10.1177/20543581251358144.
PMID: 40756446 - 16
Hungry bone syndrome after parathyroidectomy in end-stage renal disease patients: review of an alkaline phosphatase-based treatment protocol.
Wong J, Fu WH, Lim ELA, et al.
International urology and nephrology 2020; (52(3)):557-564 doi:10.1007/s11255-020-02387-0.
PMID: 32016909 - 17
Intraoperative 99mTc-MIBI-Guided Parathyroidectomy Improves Curative Effect of Parathyroidectomy, Bone Metabolism, and Bone Mineral Density.
Chen J, Feng J, Zhou Q, et al.
The American surgeon 2021; (87(3)):463-472 doi:10.1177/0003134820951467.
PMID: 33047971 - 18
Subtotal parathyroidectomy versus total parathyroidectomy with autotransplantation for secondary hyperparathyroidism: an updated systematic review and meta-analysis.
Yuan Q, Liao Y, Zhou R, et al.
Langenbeck's archives of surgery 2019; (404(6)):669-679 doi:10.1007/s00423-019-01809-7.
PMID: 31377854 - 19
Risk factors and clinical course of hungry bone syndrome after total parathyroidectomy in dialysis patients with secondary hyperparathyroidism.
Ho LY, Wong PN, Sin HK, et al.
BMC nephrology 2017; (18(1)):12 doi:10.1186/s12882-016-0421-5.
PMID: 28073343
This page is for informational purposes only and does not constitute medical advice. Your nephrologist and surgeon can explain whether parathyroidectomy and which surgical approach are appropriate for you.
Get notified when new evidence is published on secondary hyperparathyroidism of renal origin.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.